Published in Antimicrob Agents Chemother on December 28, 2009
Inaccuracy of the disk diffusion method compared with the agar dilution method for susceptibility testing of Campylobacter spp. J Clin Microbiol (2011) 1.22
Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis. Antimicrob Agents Chemother (2016) 1.15
Antagonistic activity of Lactobacillus acidophilus ATCC 4356 on the growth and adhesion/invasion characteristics of human Campylobacter jejuni. Curr Microbiol (2012) 0.88
Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (2011) 0.83
Comparison of Antimicrobial Susceptibility of Campylobacter Strains Isolated from Food Samples and Patients with Diarrhea. Iran Biomed J (2015) 0.78
In vitro susceptibility of Campylobacter jejuni from Kuwait to tigecycline & other antimicrobial agents. Indian J Med Res (2013) 0.77
Burden of laboratory-confirmed Campylobacter infections in Guatemala 2008-2012: results from a facility-based surveillance system. J Epidemiol Glob Health (2013) 0.77
Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas. BMC Microbiol (2017) 0.75
First Case Report of Campylobacter volucris Bacteremia in an Immunocompromised Patient. J Clin Microbiol (2015) 0.75
Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis (2001) 7.04
Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis (2001) 5.41
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother (2006) 2.84
Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis (1998) 2.67
Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Antimicrob Agents Chemother (2005) 2.42
Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. J Infect Dis (2005) 2.34
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. Antimicrob Agents Chemother (2005) 1.38
Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study. J Infect Dis (2006) 1.36
Antimicrobial resistance of thermophilic Campylobacter. Vet Res (2001) 1.34
Morbidity of infections caused by antimicrobial-resistant bacteria. Clin Infect Dis (2002) 1.34
Comparison of disk diffusion and agar dilution methods for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni subsp. jejuni. Antimicrob Agents Chemother (2007) 1.23
Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg Infect Dis (2004) 1.14
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors. Antimicrob Agents Chemother (1996) 1.13
Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000. J Antimicrob Chemother (2003) 1.11
Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia. Eur J Clin Microbiol Infect Dis (1992) 1.08
Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects. Antimicrob Agents Chemother (2006) 1.07
Relapsing Campylobacter coli bacteremia with reactive arthritis in a patient with X-linked agammaglobulinemia. Intern Med (2007) 1.06
Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. Emerg Infect Dis (2003) 1.05
Trends of norfloxacin and erythromycin resistance of Campylobacter jejuni/Campylobacter coli isolates recovered from international travelers, 1994 to 2006. J Travel Med (2008) 1.01
Combined treatment with oral kanamycin and parenteral antibiotics for a case of persistent bacteremia and intestinal carriage with Campylobacter coli. Intern Med (2008) 1.00
Correct identification and discrimination between Campylobacter jejuni and C. coli by a standardized hippurate test and species-specific polymerase chain reaction. Eur J Clin Microbiol Infect Dis (2008) 0.98
Macrolide-resistant Campylobacter: the meat of the matter. J Antimicrob Chemother (2007) 0.90
Patient-reported complications associated with Campylobacter jejuni infection. Epidemiol Infect (2009) 0.88
Emergence of cotrimoxazole- and quinolone-resistant Campylobacter infections in bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis (2002) 0.87
In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates. Int J Antimicrob Agents (2006) 0.87
A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature. Eur J Clin Microbiol Infect Dis (2004) 0.83
In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance. J Antimicrob Chemother (2005) 0.78
A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med (2011) 5.01
Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95
Symptoms or symptom-based scores cannot predict acute otitis media at otitis-prone age. Pediatrics (2010) 2.96
Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli). J Infect Dis (2002) 2.35
A widespread outbreak of Yersinia pseudotuberculosis O:3 infection from iceberg lettuce. J Infect Dis (2004) 2.09
Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles. J Clin Microbiol (2002) 1.85
Parallel independent evolution of pathogenicity within the genus Yersinia. Proc Natl Acad Sci U S A (2014) 1.83
Population structure of the Yersinia pseudotuberculosis complex according to multilocus sequence typing. Environ Microbiol (2011) 1.64
Ribosomal mutations in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother (2002) 1.63
Genetic diversity among clonal lineages within Escherichia coli O157:H7 stepwise evolutionary model. Emerg Infect Dis (2007) 1.62
Quality control strains used in susceptibility testing of Campylobacter spp. J Clin Microbiol (2002) 1.60
The Antimicrobial Treatment Strategies (MIKSTRA) program: a 5-year follow-up of infection-specific antibiotic use in primary health care and the effect of implementation of treatment guidelines. Clin Infect Dis (2006) 1.57
Aetiological diagnosis of community acquired pneumonia: utility of rapid microbiological methods with respect to disease severity. Scand J Infect Dis (2008) 1.57
An outbreak of gastrointestinal illness and erythema nodosum from grated carrots contaminated with Yersinia pseudotuberculosis. J Infect Dis (2006) 1.55
Effect of prophylactic antibiotics on antimicrobial resistance of viridans streptococci in the normal flora of cataract surgery patients. J Cataract Refract Surg (2004) 1.51
Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis (2004) 1.45
[Bacteriophage therapy]. Duodecim (2003) 1.39
Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11). J Antimicrob Chemother (2012) 1.35
Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (2006) 1.28
Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing. Antimicrob Agents Chemother (2005) 1.24
Inaccuracy of the disk diffusion method compared with the agar dilution method for susceptibility testing of Campylobacter spp. J Clin Microbiol (2011) 1.22
Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based finnish case-control study. Am J Epidemiol (2012) 1.19
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007. BMC Infect Dis (2010) 1.18
Comparison between cultured small-intestinal and fecal microbiotas in beagle dogs. Appl Environ Microbiol (2005) 1.17
Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2. J Clin Microbiol (2007) 1.16
Technical improvement to prevent DNA degradation of enteric pathogens in pulsed-field gel electrophoresis. J Clin Microbiol (2002) 1.16
Association between antimicrobial consumption and resistance in Escherichia coli. Antimicrob Agents Chemother (2008) 1.15
Variations in 10 putative uropathogen virulence genes among urinary, faecal and peri-urethral Escherichia coli. J Med Microbiol (2002) 1.14
Bacterial and viral etiology of childhood diarrhea in Ouagadougou, Burkina Faso. BMC Pediatr (2013) 1.13
Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype. Antimicrob Agents Chemother (2009) 1.12
New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility. J Clin Microbiol (2005) 1.11
Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000. J Antimicrob Chemother (2003) 1.11
Bacterial and viral interactions within the nasopharynx contribute to the risk of acute otitis media. J Infect (2012) 1.10
International outbreak of Salmonella Oranienburg due to German chocolate. BMC Infect Dis (2005) 1.07
Shiga toxin-producing Escherichia coli serotype O78:H(-) in family, Finland, 2009. Emerg Infect Dis (2012) 1.06
Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. Emerg Infect Dis (2003) 1.05
Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004. Scand J Infect Dis (2007) 1.04
Simultaneous quantitative analysis of FcgammaRI (CD64) expression on neutrophils and monocytes: a new, improved way to detect infections. J Immunol Methods (2007) 1.03
Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. J Antimicrob Chemother (2003) 1.03
Sporadic human Yersinia enterocolitica infections caused by bioserotype 4/O : 3 originate mainly from pigs. J Med Microbiol (2006) 1.01
Antibiotic use predicts an increased risk of cancer. Int J Cancer (2008) 1.01
Hand washing with soap and water together with behavioural recommendations prevents infections in common work environment: an open cluster-randomized trial. Trials (2012) 1.00
Genomic diversity within phage types of Salmonella enterica ssp. enterica serotypes Enteritidis and Typhimurium. Foodborne Pathog Dis (2006) 0.98
Application of molecular genetic methods in diagnostics and epidemiology of food-borne bacterial pathogens. APMIS (2005) 0.97
Mutation at the position 2058 of the 23S rRNA as a cause of macrolide resistance in Streptococcus pyogenes. Ann Clin Microbiol Antimicrob (2004) 0.97
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006. Antimicrob Agents Chemother (2009) 0.97
Domestically acquired Campylobacter infections in Finland. Emerg Infect Dis (2004) 0.97
A comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia. EJNMMI Res (2012) 0.95
Usability and performance of CHROMagar STEC medium in detection of Shiga toxin-producing Escherichia coli strains. J Clin Microbiol (2012) 0.95
Territorial waters of the Baltic Sea as a source of infections caused by Vibrio cholerae non-O1, non-O139: report of 3 hospitalized cases. Diagn Microbiol Infect Dis (2006) 0.95
gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing. Antimicrob Agents Chemother (2002) 0.94
Characterization of Shigella sonnei Isolate Carrying Shiga Toxin 2-Producing Gene. Emerg Infect Dis (2015) 0.94
Recurrent lymphocytic meningitis: the role of herpesviruses. Arch Neurol (2004) 0.94
Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J (2005) 0.93
Elimination of enteric bacteria in biological-chemical wastewater treatment and tertiary filtration units. Water Res (2003) 0.93
Macrolide-resistant group a streptococcus--now in the United States. N Engl J Med (2002) 0.92
A nationwide outbreak of multiresistant Salmonella Typhimurium in Finland due to contaminated lettuce from Spain, May 2005. Euro Surveill (2005) 0.92
Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland. Emerg Infect Dis (2009) 0.92
Evaluation of a new cellulose sponge-tipped swab for microbiological sampling: a laboratory and clinical investigation. J Clin Microbiol (2003) 0.92
Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients. J Antimicrob Chemother (2006) 0.92
Disc diffusion susceptibility testing of Haemophilus influenzae by NCCLS methodology using low-strength ampicillin and co-amoxiclav discs. J Antimicrob Chemother (2004) 0.91
The ail gene is present in some Yersinia enterocolitica biotype 1A strains. Foodborne Pathog Dis (2011) 0.91
STOPFLU: is it possible to reduce the number of days off in office work by improved hand-hygiene? Trials (2010) 0.91
Molecular epidemiology of Clostridium perfringens related to food-borne outbreaks of disease in Finland from 1984 to 1999. Appl Environ Microbiol (2002) 0.91
Symptoms and sources of Yersinia enterocolitica-infection: a case-control study. BMC Infect Dis (2010) 0.90
(68)Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. Eur J Nucl Med Mol Imaging (2007) 0.89
Multilocus variable-number tandem-repeat analysis, pulsed-field gel electrophoresis, and antimicrobial susceptibility patterns in discrimination of sporadic and outbreak-related strains of Yersinia enterocolitica. BMC Microbiol (2011) 0.89
Antimicrobial resistance of invasive pneumococci in Finland in 1999-2000. Antimicrob Agents Chemother (2003) 0.89
Connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob Agents Chemother (2008) 0.89